ArticleFrontiers in oncology2021

Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study.

Hong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.